Josephs Paul has filed 10 insider transactions across 1 company since May 2024.
Most recent transaction: a option exercise of 150000 shares of LIFECORE BIOMEDICAL, INC. DE ($LFCR) on July 08, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 8, 2025 | LIFECORE BIOMEDICAL, INC. DE | $LFCR | Josephs Paul | Chief Executive Officer | M | Common Stock | 150000 | $0.00 | 688,185.0000 | 0 | 27.87% | 0.00% |
| July 8, 2025 | LIFECORE BIOMEDICAL, INC. DE | $LFCR | Josephs Paul | Chief Executive Officer | F | Common Stock | 54857 | $8.19 | 633,328.0000 | 0 | 7.97% | 0.00% |
| July 8, 2025 | LIFECORE BIOMEDICAL, INC. DE | $LFCR | Josephs Paul | Chief Executive Officer | M | Performance-Based Restricted Stock Units | 150000 | $0.00 | 1,350,000.0000 | 0 | 10.00% | 0.00% |
| May 20, 2025 | LIFECORE BIOMEDICAL, INC. DE | $LFCR | Josephs Paul | Chief Executive Officer | F | Common Stock | 21532 | $6.63 | 538,185.0000 | 0 | 3.85% | 0.00% |
| Jan. 8, 2025 | LIFECORE BIOMEDICAL, INC. DE | $LFCR | Josephs Paul | Chief Executive Officer | P | Common Stock | 17000 | $5.74 | 559,717.0000 | 0 | 3.13% | 0.00% |
| Dec. 6, 2024 | LIFECORE BIOMEDICAL, INC. DE | $LFCR | Josephs Paul | Chief Executive Officer | F | Common Stock | 11769 | $7.15 | 542,717.0000 | 0 | 2.12% | 0.00% |
| Dec. 6, 2024 | LIFECORE BIOMEDICAL, INC. DE | $LFCR | Josephs Paul | Chief Executive Officer | A | Common Stock | 38461 | $0.00 | 554,486.0000 | 0 | 7.45% | 0.00% |
| May 20, 2024 | LIFECORE BIOMEDICAL, INC. DE | $LFCR | Josephs Paul | Chief Executive Officer | A | Common Stock | 525000 | $0.00 | 525,000.0000 | 0 | 9999.99% | 0.00% |
| May 20, 2024 | LIFECORE BIOMEDICAL, INC. DE | $LFCR | Josephs Paul | Chief Executive Officer | F | Common Stock | 8975 | $0.00 | 516,025.0000 | 0 | 1.71% | 0.00% |
| May 20, 2024 | LIFECORE BIOMEDICAL, INC. DE | $LFCR | Josephs Paul | Chief Executive Officer | A | Performance-Based Restricted Stock Units | 1500000 | $0.00 | 0.0000 | 0 | 0.00% | 0.00% |